Use of Surgify Safety Burr in Hard Tissue Cutting, Head and Spine Area

November 29, 2022 updated by: Nuutti Vartiainen, Surgify Medical Oy

Surgify2021. Use of Surgify Safety Burr in Hard Tissue Cutting, Head and Spine Area.

Purpose of the study: To evaluate whether the SSB is safe, useful, beneficial and effective in drilling, cutting and removal of bone tissue in neurosurgical and spine procedures.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Sponsored observational clinical pilot study with no control group. Aim is to get a maximum of 20 study subjects, who have disease of the spine or head requiring surgery with bone removal and who are willing to participate into this study.

Study Type

Observational

Enrollment (Actual)

22

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Helsinki, Finland, 00290
        • HUS,Töölö hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Any 18 to 70 -year old patient scheduled to back/head operation can be recruited according to other inclusion and exclusion criteria.

Description

Inclusion Criteria:

  • Disease of the spine or head requiring surgery with bone removal
  • Ability to understand the purpose and risks of the study and to give written informed consent
  • Age 18-70 years

Exclusion Criteria:

  • Previous surgery on the same area
  • Abnormalities of bone tissue
  • Vulnerable patient (such as prisoner, retarded person, person in nursing home, patient in emergency situation)
  • Allergy or hypersensitivity to medical-grade stainless steel or any of alloying components
  • Problems with blood clotting

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Other

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To evaluate usability of SSB
Time Frame: Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
Using video material from operations, microphone recording of the surgeon commentary during drilling and questionnaires to surgeon.
Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
To evaluate safety of SSB
Time Frame: Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
AE reporting
Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To evaluate effectiveness of SSB
Time Frame: Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
Using video material from operations, microphone recording of the surgeon commentary during drilling
Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
To evaluate beneficiality of SSB
Time Frame: Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week
Questionnaires to surgeon
Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nuutti Vartiainen, MD, PhD, HUS

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2022

Primary Completion (Actual)

October 13, 2022

Study Completion (Actual)

November 17, 2022

Study Registration Dates

First Submitted

January 25, 2022

First Submitted That Met QC Criteria

February 25, 2022

First Posted (Actual)

March 8, 2022

Study Record Updates

Last Update Posted (Actual)

November 30, 2022

Last Update Submitted That Met QC Criteria

November 29, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Surgify2021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on Surgify Safety Burr

Subscribe